Advertisement
OtherDrug Discovery and Translational Medicine

Fate determination role of erythropoietin and romiplostim in the lineage commitment of hematopoietic progenitors

Xiaoqing Fan, Wojciech Krzyzanski, Raymond S. M. Wong and Xiaoyu Yan
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2022-001130; DOI: https://doi.org/10.1124/jpet.122.001130

Article Information

JPET-AR-2022-001130
DOI 
https://doi.org/10.1124/jpet.122.001130
PubMed 
35489782
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online April 30, 2022.
Copyright & Usage 
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Xiaoqing Fan1,
  2. Wojciech Krzyzanski2,
  3. Raymond S. M. Wong3, and
  4. Xiaoyu Yan1,*
  1. 1School of Pharmacy, The Chinese University of Hong Kong, Hong Kong
  2. 2Pharmaceutical Sciences, University at Buffalo, United States
  3. 3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong
  1. ↵* Corresponding Author:
    Xiaoyu Yan, School of Pharmacy, The Chinese University of Hong Kong, Hong Kong, N/A, Hong Kong. E-mail: xiaoyuyan{at}cuhk.edu.hk

Statistics from Altmetric.com

Article usage

Article usage: April 2022 to May 2022

AbstractFullPdf
Apr 20222200
May 2022134074

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherDrug Discovery and Translational Medicine

Fate determination role of erythropoietin and romiplostim

Xiaoqing Fan, Wojciech Krzyzanski, Raymond S. M. Wong and Xiaoyu Yan
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2022-001130; DOI: https://doi.org/10.1124/jpet.122.001130
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Advertisement